131 related articles for article (PubMed ID: 9684879)
1. Increased caveolin-3 levels in mdx mouse muscles.
Vaghy PL; Fang J; Wu W; Vaghy LP
FEBS Lett; 1998 Jul; 431(1):125-7. PubMed ID: 9684879
[TBL] [Abstract][Full Text] [Related]
2. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle.
Gossrau R
Acta Histochem; 1998 Feb; 100(1):99-112. PubMed ID: 9542584
[TBL] [Abstract][Full Text] [Related]
4. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain.
Venema VJ; Ju H; Zou R; Venema RC
J Biol Chem; 1997 Nov; 272(45):28187-90. PubMed ID: 9353265
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
[TBL] [Abstract][Full Text] [Related]
6. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters.
Segal SS; Brett SE; Sessa WC
Am J Physiol; 1999 Sep; 277(3):H1167-77. PubMed ID: 10484439
[TBL] [Abstract][Full Text] [Related]
7. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase.
Wehling M; Stull JT; McCabe TJ; Tidball JG
Neuromuscul Disord; 1998 Feb; 8(1):22-9. PubMed ID: 9565987
[TBL] [Abstract][Full Text] [Related]
8. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.
Chao DS; Silvagno F; Bredt DS
J Neurochem; 1998 Aug; 71(2):784-9. PubMed ID: 9681470
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1, caveolin-3 and VEGF expression in the masticatory muscles of mdx mice.
Kunert-Keil C; Gredes T; Lucke S; Morgenstern S; Mielczarek A; Sporniak-Tutak K; Gedrange T; Spassov A
Folia Histochem Cytobiol; 2011; 49(2):291-8. PubMed ID: 21744331
[TBL] [Abstract][Full Text] [Related]
10. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
12. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.
Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C
Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463
[TBL] [Abstract][Full Text] [Related]
13. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
15. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
16. TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy.
Gervásio OL; Whitehead NP; Yeung EW; Phillips WD; Allen DG
J Cell Sci; 2008 Jul; 121(Pt 13):2246-55. PubMed ID: 18544631
[TBL] [Abstract][Full Text] [Related]
17. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
18. Changes in the distribution and density of caveolin 3 molecules at the plasma membrane of mdx mouse skeletal muscles: a fracture-label electron microscopic study.
Shibuya S; Wakayama Y; Inoue M; Oniki H; Kominami E
Neurosci Lett; 2002 Jun; 325(3):171-4. PubMed ID: 12044648
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.
Sunada Y; Ohi H; Hase A; Ohi H; Hosono T; Arata S; Higuchi S; Matsumura K; Shimizu T
Hum Mol Genet; 2001 Feb; 10(3):173-8. PubMed ID: 11159934
[TBL] [Abstract][Full Text] [Related]
20. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
